Previous close | 26.03 |
Open | 25.85 |
Bid | 25.95 x 0 |
Ask | 25.99 x 0 |
Day's range | 25.83 - 25.99 |
52-week range | 23.53 - 37.50 |
Volume | |
Avg. volume | 77,389 |
Market cap | 147.246B |
Beta (5Y monthly) | 0.58 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.56 (5.99%) |
Ex-dividend date | 09 May 2024 |
1y target est | N/A |
Pfizer Inc. ( NYSE:PFE ) just released its first-quarter report and things are looking bullish. It was overall a...
As the big drugmaker tries to turn its fortunes around by focusing on oncology, it has turned to a Citi analyst who hasn’t recommended the stock in over a decade. But Andrew Baum has something Pfizer needs: oncology expertise.
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Visa Inc. (V) and Pfizer Inc. (PFE).